Spatiotemporal control and modeling of morphogen delivery to induce gradient patterning of stem cell differentiation using fluidic channels.


Journal

Biomaterials science
ISSN: 2047-4849
Titre abrégé: Biomater Sci
Pays: England
ID NLM: 101593571

Informations de publication

Date de publication:
26 Mar 2019
Historique:
pubmed: 20 2 2019
medline: 30 7 2019
entrez: 20 2 2019
Statut: ppublish

Résumé

The process of cell differentiation in a developing embryo is influenced by numerous factors, including various biological molecules whose presentation varies dramatically over space and time. These morphogens regulate cell fate based on concentration profiles, thus creating discrete populations of cells and ultimately generating large, complex tissues and organs. Recently, several in vitro platforms have attempted to recapitulate the complex presentation of extrinsic signals found in nature. However, it has been a challenge to design versatile platforms that can dynamically control morphogen gradients over extended periods of time. To address some of these issues, we introduce a platform using channels patterned in hydrogels to deliver multiple morphogens to cells in a 3D scaffold, thus creating a spectrum of cell phenotypes based on the resultant morphogen gradients. The diffusion coefficient of a common small molecule morphogen, retinoic acid (RA), was measured within our hydrogel platform using Raman spectroscopy and its diffusion in our platform's geometry was modeled using finite element analysis. The predictive model of spatial gradients was validated in a cell-free hydrogel, and temporal control of morphogen gradients was then demonstrated using a reporter cell line that expresses green fluorescent protein in the presence of RA. Finally, the utility of this approach for regulating cell phenotype was demonstrated by generating opposing morphogen gradients to create a spectrum of mesenchymal stem cell differentiation states.

Identifiants

pubmed: 30778445
doi: 10.1039/c8bm01199k
pmc: PMC6485939
mid: NIHMS1013338
doi:

Types de publication

Journal Article

Langues

eng

Pagination

1358-1371

Subventions

Organisme : NIBIB NIH HHS
ID : R00 EB013630
Pays : United States
Organisme : NIA NIH HHS
ID : T32 AG058524
Pays : United States
Organisme : NIGMS NIH HHS
ID : T32 GM007347
Pays : United States

Références

Acta Biomater. 2017 Jul 15;57:1-25
pubmed: 28088667
Dev Biol. 2016 Dec 15;420(2):199-209
pubmed: 27402594
Integr Biol (Camb). 2012 May;4(5):461-70
pubmed: 22388577
Mol Syst Biol. 2015 Jul 14;11(7):815
pubmed: 26174932
J Control Release. 2009 Mar 4;134(2):81-90
pubmed: 19071168
J Cell Sci. 1992 Jul;102 ( Pt 3):427-36
pubmed: 1506425
Science. 2008 Dec 19;322(5909):1857-61
pubmed: 19095943
Dev Biol. 2004 Nov 1;275(1):44-67
pubmed: 15464572
Kidney Res Clin Pract. 2015 Sep;34(3):165-9
pubmed: 26484042
PLoS One. 2013 Nov 28;8(11):e82382
pubmed: 24312418
Nat Biotechnol. 2014 Aug;32(8):795-803
pubmed: 25093887
Nat Biotechnol. 2015 Sep;33(9):970-9
pubmed: 26192318
Exp Cell Res. 2001 Aug 15;268(2):189-200
pubmed: 11478845
Adv Drug Deliv Rev. 2012 Sep;64(12):1292-309
pubmed: 22342771
Cell. 2015 Jan 15;160(1-2):299-312
pubmed: 25533785
J Control Release. 2001 Nov 9;77(1-2):97-105
pubmed: 11689263
Sci Rep. 2014 Mar 25;4:4462
pubmed: 24662945
Trends Mol Med. 2017 Mar;23(3):246-263
pubmed: 28188103
Can J Chem Eng. 2010 Dec;88(6):899-911
pubmed: 21874065
Trends Biotechnol. 2013 Feb;31(2):78-84
pubmed: 23219200
Nat Rev Genet. 2005 Nov;6(11):826-35
pubmed: 16304598
Dev Biol. 2018 Feb 1;434(1):121-132
pubmed: 29217200
Nanoscale Res Lett. 2017 Dec;12(1):86
pubmed: 28168610
Nat Methods. 2017 Jul;14(7):743-751
pubmed: 28504681
Sci Rep. 2013;3:1316
pubmed: 23419835
Cell Rep. 2016 Jun 28;16(1):66-78
pubmed: 27320915
Lab Chip. 2015 Jun 21;15(12):2688-99
pubmed: 25996126
PLoS Biol. 2014 Aug 26;12(8):e1001937
pubmed: 25157815
Nat Rev Drug Discov. 2015 Apr;14(4):248-60
pubmed: 25792263
Small. 2016 Feb 3;12(5):612-22
pubmed: 26619365
Tissue Barriers. 2016 Jan 28;4(1):e1142493
pubmed: 27141422
Development. 2017 Mar 15;144(6):998-1007
pubmed: 28292846
Development. 2016 Jun 1;143(11):1884-92
pubmed: 27246712
Chem Soc Rev. 2017 Oct 30;46(21):6532-6552
pubmed: 28820527
Stem Cell Reports. 2015 Apr 14;4(4):632-44
pubmed: 25843047
J Control Release. 2016 Feb 10;223:126-136
pubmed: 26721447
Science. 1999 Apr 2;284(5411):143-7
pubmed: 10102814
Curr Eye Res. 2002 Jan;24(1):66-74
pubmed: 12187497
J Cell Biochem. 1997 Feb;64(2):295-312
pubmed: 9027589
Bioessays. 2008 Sep;30(9):811-21
pubmed: 18693260
Lab Chip. 2010 Apr 21;10(8):939-56
pubmed: 20358102
Cell Stem Cell. 2017 Aug 3;21(2):151-152
pubmed: 28777937
Nat Rev Mol Cell Biol. 2015 Feb;16(2):110-23
pubmed: 25560970
Tissue Eng. 1998 Winter;4(4):415-28
pubmed: 9916173
Nat Protoc. 2018 Apr;13(4):723-737
pubmed: 29543795
Appl Spectrosc. 2003 Jul;57(7):768-73
pubmed: 14658654
Biomaterials. 2010 Aug;31(24):6279-308
pubmed: 20493521
Trends Biotechnol. 2011 Aug;29(8):399-408
pubmed: 21549437
Am J Med Genet C Semin Med Genet. 2005 May 15;135C(1):2-8
pubmed: 15806586
Nat Rev Mol Cell Biol. 2014 Jan;15(1):19-33
pubmed: 24326621

Auteurs

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH